Cardio Vascular Products Articles & Analysis
9 news found
Bodyport, the digital health company focused on the detection and management of heart disease, today announced that it has named Amit Rushi as Chief Commercial Officer (CCO) and Phyllis Whiteley as Chair of the Board of Directors. With this newly created role, Amit Rushi will serve as part of the executive team and prepare the organization for commercialization and growth. As Chair of the Board, ...
Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid well-documented risks of perforation, migration, fracture, and thrombosis currently associated with IVC filters. Such safety issues have been the focus of ...
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been nominated in the French Tech 120 of the 2022 program. French Tech 120 is a growth-stage program by La FrenchTech, built to provide government-backed support for the 120 fastest growing companies in France. This is the third year in a row that ...
ByTISSIUM
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Ruth Krestin as Vice President of Portfolio Strategy within TISSIUM. In this role, she will be responsible for coordinating TISSIUM’s verticals and driving an efficient portfolio-level strategy. Ms. Krestin joins TISSIUM with extensive ...
ByTISSIUM
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, will present an e-poster on its research on a novel, atraumatic, and consistent hernia mesh fixation device at the Hernia 2021 European Hernia Society – American Hernia Society Joint Congress. The event is scheduled to be held virtually and in-person from October 13 – ...
ByTISSIUM
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has announced its research has been selected for presentation within the scientific program at the 76th Annual Meeting of the American Society for Surgery of the Hand. The event is scheduled to be held virtually and in-person from September 30 – October 2, 2021 in San Francisco, ...
ByTISSIUM
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series C round of financing, raising €50 million from new and existing international investors. Cathay Health, affiliated to global investment firm Cathay Capital, led new investors and joined other institutional and individual backers while existing ...
ByTISSIUM
Nipro Medical Corporation (NMC), a leading Renal, Medical, Surgical, and Interventional Radiology products manufacturer, announces the creation of a Vascular Division in the U.S. The division will include several cutting-edge technologies, innovative vascular and cardiovascular products to provide clinicians with procedural and imaging solutions that enhance patient care. To support the new ...
In ongoing efforts to protect people’s health, the U.S. Environmental Protection Agency is collaborating with the Poison Prevention Week Council to encourage the public to keep poisonous substances out of the hands of children. In observance of National Poison Prevention Week (March 20-26), EPA recommends that locking household cleaners, disinfectants, solvents and other materials is the ...